UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2000-05, Vol.283 (18), p.2417

2000

Volltextzugriff (PDF)

The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living Donors

American journal of transplantation, 2016-12, Vol.16 (12), p.3385-3391

2016

Volltextzugriff (PDF)

Oxidant Stress Is Increased during Treatment of Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2003-12, Vol.37 (12), p.1711-1717

2003

Volltextzugriff (PDF)

Immune control of HIV-1 after early treatment of acute infection

Nature (London), 2000-09, Vol.407 (6803), p.523-526

2000

Volltextzugriff (PDF)

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

JAMA : the journal of the American Medical Association, 1999-09, Vol.282 (12), p.1142

1999

Volltextzugriff (PDF)

Antiretroviral Resistance during Successful Therapy of HIV Type 1 Infection

Proceedings of the National Academy of Sciences - PNAS, 2000-09, Vol.97 (20), p.10948-10953

2000

Volltextzugriff (PDF)

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel

Clinical infectious diseases, 2003-07, Vol.37 (1), p.113-128

2003

Volltextzugriff (PDF)

Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral Chemotherapy

Clinical infectious diseases, 2001-03, Vol.32 (5), p.774-782

2001

Volltextzugriff (PDF)

Assessment of Factors Associated With the Evaluation of Children for Leukemia Predisposition Syndromes: A Retrospective Single-center Study

Journal of pediatric hematology/oncology, 2023-07, Vol.45 (5), p.e597-e602

2023

Volltextzugriff (PDF)

Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

The Journal of infectious diseases, 1998-01, Vol.177 (1), p.40-47

1998

Volltextzugriff (PDF)

Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

The New England journal of medicine, 2003-12, Vol.349 (24), p.2304-2315

2003

Volltextzugriff (PDF)

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

JAMA : the journal of the American Medical Association, 2001-07, Vol.286 (2), p.196

2001

Volltextzugriff (PDF)

Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

Journal of Virology, 1999-05, Vol.73 (5), p.3744-3752

1999

Volltextzugriff (PDF)

Accuracy of the TRUGENE HIV-1 Genotyping Kit

Journal of Clinical Microbiology, 2003-04, Vol.41 (4), p.1586-1593

2003

Volltextzugriff (PDF)

Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level with Risk of Clinical Progression in Patients with Advanced Infection

The Journal of infectious diseases, 1996-10, Vol.174 (4), p.704-712

1996

Volltextzugriff (PDF)

Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection

The Journal of infectious diseases, 1999-04, Vol.179 (4), p.808-816

1999

Volltextzugriff (PDF)

Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites

Journal of Virology, 2000-11, Vol.74 (22), p.10269-10273

2000

Volltextzugriff (PDF)

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

AIDS (London), 2002-05, Vol.16 (7), p.1009-1017

2002

Volltextzugriff (PDF)

The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)

The Journal of infectious diseases, 2000-05, Vol.181 (5), p.1622-1628

2000

Volltextzugriff (PDF)

Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy, 1999-01, Vol.43 (1), p.121-128

1999

Volltextzugriff (PDF)

Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine Treatment

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1172-1179

1995

Volltextzugriff (PDF)

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

Antimicrobial Agents and Chemotherapy, 1994-02, Vol.38 (2), p.282-287

1994

Volltextzugriff (PDF)

Eugenol Induces Phenotypic Alterations and Increases the Oxidative Burst in Cryptococcus

Frontiers in microbiology, 2017-12, Vol.8, p.2419-2419

2017

Volltextzugriff (PDF)

Patterns of Resistance Mutations Selected by Treatment of Human Immunodeficiency Virus Type 1 Infection with Zidovudine, Didanosine, and Nevirapine

The Journal of infectious diseases, 2000-03, Vol.181 (3), p.904-911

2000

Volltextzugriff (PDF)

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates

Antimicrobial agents and chemotherapy, 1993, Vol.37 (5), p.1095-1101

1993

Volltextzugriff (PDF)

1 – 25 von 543

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(494)
Mit Volltextzugriff
(462)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel

The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living Donors

Oxidant Stress Is Increased during Treatment of Human Immunodeficiency Virus Infection

Immune control of HIV-1 after early treatment of acute infection

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

Antiretroviral Resistance during Successful Therapy of HIV Type 1 Infection

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel

Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral Chemotherapy

Assessment of Factors Associated With the Evaluation of Children for Leukemia Predisposition Syndromes: A Retrospective Single-center Study

Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

Accuracy of the TRUGENE HIV-1 Genotyping Kit

Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level with Risk of Clinical Progression in Patients with Advanced Infection

Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection

Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)

Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients

Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine Treatment

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

Eugenol Induces Phenotypic Alterations and Increases the Oxidative Burst in Cryptococcus

Patterns of Resistance Mutations Selected by Treatment of Human Immunodeficiency Virus Type 1 Infection with Zidovudine, Didanosine, and Nevirapine

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates

Suchergebnisse filtern